SENSEX NIFTY

Glenmark Pharmaceuticals

Jan 17, 2017 at 21:16 | Source: Moneycontrol.com
Glenmark Pharmaceuticals' board meeting will be held on February 02, 2017, to consider and approve the Company's Unaudited Financial Statements for the Third Quarter and Nine months ended December 31, 2016 (Q3). Further, as per the
Jan 17, 2017 at 16:02 | Source: Moneycontrol.com
Net Sales are expected to increase by 0.9 percent Q-o-Q (down 27.1 percent Y-o-Y) to Rs 2190 crore, according to HDFC Securities.
Jan 16, 2017 at 12:17 | Source: Moneycontrol.com
Net Sales are expected to increase by 11.6 percent Q-o-Q (up 39.6 percent Y-o-Y) to Rs 2482.5 crore, according to ICICI Securities.
Jan 14, 2017 at 14:00 | Source: Moneycontrol.com
Analysts predict Q3 to be a tough quarter with revenue growth moderating to 11.7 percent in October-December period compared to 18.4 percent compounded annual growth rate (CAGR) over last 10 years
Jan 12, 2017 at 12:29 | Source: CNBC-TV18
Here are a few top buzzing stocks picked by CNBC-TV18's analysts in trade today -- Idea Cellular, Sun Pharma, DRL, Lupin, Aurobindo Pharma , Glenmark, Natco Pharma, Alkem Labs, Ajanta Pharma, Strides Shasun, Biocon, Cipla, Cyient, MMTC and Power Grid.
Jan 06, 2017 at 09:53 | Source: CNBC-TV18
Speaking to CNBC-TV18 Sandeep Bhatia, Head of Equity, India at Macquarie said that markets could trend down over the next couple of months. Any 10 percent correction from current levels will be reasonable, he maintained.
Jan 06, 2017 at 08:01 | Source: CNBC-TV18
Wockhardt | Tech Mahindra | Sagar Cement | Glenmark | Torrent Pharma | Mastek | Piramal Enterprises | GE Power | Indo Borax | Monnet Ispat | Reliance Communications | GM Breweries and Chartered Logistics are stocks, which are in the news today.
Jan 03, 2017 at 15:04 | Source: CNBC-TV18
Rajat Bose of rajatkbose.com recommends buying IL&FS Transport and Glenmark Pharma.
Jan 03, 2017 at 09:29 | Source: CNBC-TV18
Mitesh Thacker of miteshthacker.com suggests buying Cummins India and NBCC and advises selling Glenmark Pharma.
Dec 30, 2016 at 08:22 | Source: Moneycontrol.com
Nomura is neutral on Lupin and Torrent. It has a buy rating on Dr Reddys and Cadila. It says trailing three-month sales declined sequentially for Torrent, Sun Pharma and Glenmark. Torrents sales were down on account of price erosion in gAbilify. Suns T3M sales declined QoQ due to price erosion and market share loss in gGleevec.
Messages on Glenmark Pharmaceuticals »

BSE/NSE Announcer

Platinum Member

20267 Followers

Glenmark  

Glenmark Pharmaceuticals' board meeting will be held on February 02, 2017, to consider and approve the Company's Unaudited Financial Statements for the Third Quarter and Nine months ended December 31, 2016 (Q3). Further, as per the

9.16 PM Jan 17th

BSE/NSE Announcer

Platinum Member

20267 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

11.25 AM Jan 12th

Arvind Dhakad

New Member

2 Followers

Just Posted  

pharmaceuticals sector-3qfy17 range-bound performance likely: we expect most large pharmaceutical companies in 3qfy17 to continue to consolidate around their earnings peak level witnessed a couple of quarters ago. glenmark pharmaceuticals and natco pharma should be the bright spots registering new

11.51 AM Jan 11th

ajaydevgun5
55

New Member

7 Followers

Glenmark  

goldman sachs initiated coverage on glenmark pharmaceuticals with ‘buy’ rating with a target price of rs 925

1.12 PM Jan 2nd

diyapilly

New Member

2 Followers

Glenmark  

new delhi: glenmark pharmaceuticals has received a final approval from the us food and drug administration (fda) for sale of tretinoin capsules, used in treatment of leukemia. big news target rerated at 950 soon intraday target 915 930 945

10.42 AM Jan 2nd

Wire News

Platinum Member

693 Followers

News Now  

Glenmark Pharmaceuticals has received final approval from the US health regulator USFDA for sale of Tretinoin Capsules, used in treatment of leukemia.

11.46 AM Dec 27th 2016

BSE/NSE Announcer

Platinum Member

20267 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 27, 2016, titled "Glenmark Pharmaceuticals receives ANDA approval for Tretinoin Capsules, 10 mg".

10.13 AM Dec 27th 2016

Wire News

Platinum Member

693 Followers

News Now  

Pharma major Glenmark Pharmaceuticals today said it has chalked out USD 300 million capital expenditure plans over the next three years.

7.46 PM Dec 19th 2016

BSE/NSE Announcer

Platinum Member

20267 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated December 19, 2016 titled "Glenmark Unveils its Strategic Blueprint for Transition into an Innovation?]Led Global Pharmaceutical Organization in the Next Decade".

2.35 PM Dec 19th 2016

BSE/NSE Announcer

Platinum Member

20267 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates.

2.01 PM Dec 14th 2016

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.